Towards random sequencing or precision medicine in castration-resistant prostate cancer?
- PMID: 24075577
- DOI: 10.1016/j.eururo.2013.09.019
Towards random sequencing or precision medicine in castration-resistant prostate cancer?
Comment on
-
Enzalutamide in castration-resistant prostate cancer patients progressing after docetaxel and abiraterone.Eur Urol. 2014 Jan;65(1):30-6. doi: 10.1016/j.eururo.2013.06.042. Epub 2013 Jul 2. Eur Urol. 2014. PMID: 23849416
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
